COSTA, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 2.158
AS - Asia 1.114
EU - Europa 1.057
AF - Africa 28
SA - Sud America 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.372
Nazione #
US - Stati Uniti d'America 2.093
SG - Singapore 535
IT - Italia 484
HK - Hong Kong 271
CN - Cina 267
NL - Olanda 121
FR - Francia 116
IE - Irlanda 109
FI - Finlandia 72
CA - Canada 56
SE - Svezia 34
DE - Germania 31
RU - Federazione Russa 29
CI - Costa d'Avorio 23
GB - Regno Unito 20
IN - India 16
VN - Vietnam 12
ES - Italia 8
UA - Ucraina 8
AU - Australia 6
BR - Brasile 5
CZ - Repubblica Ceca 5
MX - Messico 5
TR - Turchia 4
CH - Svizzera 3
GR - Grecia 3
HR - Croazia 3
PL - Polonia 3
PR - Porto Rico 3
TN - Tunisia 3
BE - Belgio 2
EG - Egitto 2
EU - Europa 2
PT - Portogallo 2
AM - Armenia 1
AR - Argentina 1
EC - Ecuador 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
LI - Liechtenstein 1
LT - Lituania 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
Totale 4.372
Città #
Singapore 447
Hong Kong 270
Chandler 249
Santa Clara 249
Ashburn 152
Millbury 146
Naples 126
Amsterdam 109
Des Moines 99
Princeton 91
Boston 82
Napoli 81
Nanjing 69
Lawrence 57
Ottawa 46
Beijing 42
Wilmington 41
Milan 27
Nanchang 26
Cava de' Tirreni 23
Seattle 18
Dublin 17
Washington 16
Rome 15
Hangzhou 13
Hebei 13
Dong Ket 12
Helsinki 12
Jacksonville 12
Redwood City 12
Woodbridge 12
Boardman 11
Shenyang 11
Fairfield 10
Jiaxing 9
Toronto 9
Kunming 8
Changsha 7
Tianjin 7
Fuzhou 6
Springfield 6
Brno 5
Lanzhou 5
Norwalk 5
Shanghai 5
Campinas 4
Campoli del Monte Taburno 4
Falkenstein 4
Fremont 4
Guangzhou 4
Los Angeles 4
Marano Di Napoli 4
Moscow 4
Paris 4
Prineville 4
The Dalles 4
Ankara 3
Ann Arbor 3
Battipaglia 3
Caserta 3
Cassano d'Adda 3
Castel San Giorgio 3
Coimbatore 3
Houston 3
Indiana 3
Kronberg 3
Mexico City 3
Newcastle-under-Lyme 3
Pune 3
San Juan 3
Sydney 3
Torre Del Greco 3
Treviso 3
Aversa 2
Bari 2
Bologna 2
Brisbane 2
Cagliari 2
Casalnuovo di Napoli 2
Casoria 2
Changchun 2
Chennai 2
Columbus 2
Cuauhtémoc 2
Custonaci 2
Ferrara di Monte Baldo 2
Florence 2
Funchal 2
Giugliano in Campania 2
Karditsa 2
Kerken 2
Kolkata 2
Lausanne 2
Lusciano 2
Modena 2
Nantes 2
Nola 2
Orange 2
Phoenix 2
Romainville 2
Totale 2.837
Nome #
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 75
Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization 57
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 54
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 53
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 51
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept 51
The use of TNF-? blockers in psoriatic arthritis patients with latent tuberculosis infection. 50
Small molecule therapy for managing moderate to severe psoriatic arthritis 50
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 49
Fragility Fractures in Patients with Psoriatic Arthritis 49
Dactylitis in enteropathic spondyloarthritis 48
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 46
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 46
Screening and Monitoring of Latent Tubercular Infection in Patients Taking Tumor Necrosis Factor-α Blockers for Psoriatic Arthritis 45
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study 44
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. 43
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 43
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 41
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment 41
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 41
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 41
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 40
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 40
La gravidanza nelle malattie autoimmuni: il rischio per la madre, per il feto e per il neonato. 39
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome 39
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 39
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 39
Blockade of intra-articular TNF in peripheral spondyloarthritis: Its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers 38
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. 38
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 38
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 38
Magnetic resonance imaging of nail unit in psoriatic arthritis 38
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 38
Blau syndrome and latent tubercular infection: an unresolved partnership 37
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease 36
Simple clinical indicators for early psoriatic arthritis detection 36
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 36
Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment 36
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 36
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 35
Psoriatic arthritis and psoriasis: differential diagnosis 35
Decrease of serum C-reactive protein levels in psoriatic arthritis patients treated with TNF alpha blockers 35
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 35
Treatment options: NSAIDs and DMARDs 34
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 34
Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy: An observational study 34
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 34
The enthesopathy of celiac patients: Effects of gluten-free diet 34
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 33
Biological treatments in Behçet's disease: beyond anti-TNF therapy 33
Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: The ULISSE study 33
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 33
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 33
Early Psoriatic Arthritis 31
The definition and measurement of axial psoriatic arthritis 31
From autoinflammation to autoimmunity: old and recent findings 30
Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis 30
Serum amyloid-A in Beh?et's disease. 30
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints 30
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: A retrospective observational multicenter study on 15 patients 30
Early psoriatic arthritis 30
Epidemiologia ed aspetti socioeconomici dell’osteoporosi. 29
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 29
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease 29
Scores versus clinical profiles in therapeutic decisions: a positive example from the Italian Medicines Agency (AIFA) decisions in the field of osteoporosis 29
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 29
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 29
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 28
Osteoporosis and psoriatic arthritis. 28
JAK/STAT/PKC? molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis 28
Emerging drugs for psoriatic arthritis 28
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 28
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study 28
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 28
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment 28
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 28
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 28
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 27
Refractory pemphigus foliaceus and Beh?et?s disease successfully treated with tocilizumab 27
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 27
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 27
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study 27
Ex vivo signaling protein mapping in T lymphocytes in the psoriatic arthritis joints 26
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 26
Interaction between microbiome and host genetics in psoriatic arthritis 26
Ultrasonographic Evidence of Predominance of Acute Extracapsular and Chronic Intrasynovial Patterns in 100 Cases of Psoriatic Hand Dactylitis 26
The ClASsification for Psoriatic ARthritis (CASPAR) Criteria - A Retrospective Feasibility, Sensitivity, and Specificity Study 25
Psoriatic disease: Clinical staging 25
Role of agents other than tumor necrosis factor blockers in the treatment of psoriatic arthritis 25
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis 25
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 25
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 25
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules". 25
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 25
Psoriatic disease: Clinical staging 25
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? 24
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 24
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis 24
The enthesopathy of celiac patients: effects of gluten-free diet 23
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. 23
Totale 3.452
Categoria #
all - tutte 24.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 0 0 0 0 0 0 4 1 8 24 46 51
2020/2021234 42 2 10 15 28 29 6 4 51 10 20 17
2021/2022690 8 8 2 0 2 30 1 32 109 33 124 341
2022/2023765 149 23 24 38 91 78 5 73 95 114 65 10
2023/2024721 31 113 116 49 38 87 21 44 7 12 126 77
2024/20251.440 316 299 22 79 80 297 347 0 0 0 0 0
Totale 4.643